Risk for SARS-CoV-2 Infection in Healthcare Workers, Turin, Italy
Andrea Calcagno, Valeria Ghisetti, Teresa Emanuele, Mattia Trunfio, Silvia Faraoni, Lucio Boglione, Elisa Burdino, Sabrina Audagnotto, Filippo Lipani, Marco Nigra, Antonio D’Avolio, Stefano Bonora, Giovanni Di Perri
Abstract
We measured severe acute respiratory syndrome coronavirus 2 spike protein subunits S1/S2 antibodies by using capillary electrophoresis and a chemiluminescence immunoassay for 5,444 active healthcare workers in Italy. Seroprevalence was 6.9% and higher among participants having contact with patients. Seroconversion was not observed in 37/213 previously infected participants.
Topics & Concepts
SeroprevalenceSeroconversionSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MedicineCoronavirus disease 2019 (COVID-19)ImmunoassayVirology2019-20 coronavirus outbreakCoronavirusAntibodyHealth careImmunologySerologyInternal medicineOutbreakDiseaseInfectious disease (medical specialty)Economic growthEconomicsSARS-CoV-2 and COVID-19 ResearchSARS-CoV-2 detection and testingBiosensors and Analytical Detection